Ran Nir‐Paz

ORCID: 0000-0002-1567-2550
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Microbial infections and disease research
  • Bacteriophages and microbial interactions
  • Pneumonia and Respiratory Infections
  • Respiratory viral infections research
  • Listeria monocytogenes in Food Safety
  • Antibiotic Resistance in Bacteria
  • Cancer Research and Treatments
  • Streptococcal Infections and Treatments
  • Neonatal and Maternal Infections
  • Genomics and Phylogenetic Studies
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • COVID-19 and Mental Health
  • COVID-19 epidemiological studies
  • Antimicrobial Resistance in Staphylococcus
  • Bacterial Identification and Susceptibility Testing
  • Bacterial Infections and Vaccines
  • Antibiotics Pharmacokinetics and Efficacy
  • Biomedical Ethics and Regulation
  • Antibiotic Use and Resistance
  • Herpesvirus Infections and Treatments
  • Olfactory and Sensory Function Studies
  • Vibrio bacteria research studies
  • Hepatitis B Virus Studies
  • Infection Control and Ventilation

Hadassah Medical Center
2015-2024

Hebrew University of Jerusalem
2009-2024

Comer Children's Hospital
2023

European Society of Clinical Microbiology and Infectious Diseases
2023

Institut de Recherche Vaccinale
2022

University Medical Center
2003-2021

Active Implants (United States)
2019

Israel Ministry of Health
2015

University of California, Berkeley
2005-2011

Sidney Kimmel Cancer Center
2011

Abstract Purpose: Listeria monocytogenes (Lm)-based vaccines stimulate both innate and adaptive immunity. ANZ-100 is a live-attenuated Lm strain (Lm ΔactA/ΔinlB). Uptake by phagocytes in the liver results local inflammatory responses activation recruitment of natural killer (NK) T cells, association with increased survival mice bearing hepatic metastases. The ΔactA/ΔinlB strain, engineered to express human mesothelin (CRS-207), tumor-associated antigen expressed variety tumors, induces...

10.1158/1078-0432.ccr-11-2121 article EN Clinical Cancer Research 2011-12-07

Here, we show that interleukin-1 (IL-1) enhances antigen-driven CD8 T cell responses. When administered to recipients of OT-I receptor transgenic cells specific for an ovalbumin (OVA) peptide, IL-1 results in increase the numbers wild-type but not IL1R1−/− cells, particularly spleen, liver, and lung, upon immunization with OVA lipopolysaccharide. administration also enhancement frequency antigen-specific are granzyme B+, have cytotoxic activity, and/ or produce interferon γ (IFN-γ). Cells...

10.1084/jem.20122006 article EN cc-by-nc-sa The Journal of Experimental Medicine 2013-03-04

A patient with a trauma-related left tibial infection associated extensively drug-resistant Acinetobacter baumannii and multidrug-resistant Klebsiella pneumoniae was treated bacteriophages antibiotics. There rapid tissue healing positive culture eradication. As result, the patient's leg did not have to be amputated he is undergoing rehabilitation.

10.1093/cid/ciz222 article EN Clinical Infectious Diseases 2019-03-13

Mycoplasma pneumoniae is a common cause of respiratory tract infections with community-acquired pneumonia as the major disease-related burden. Compared other pathogens, M atypical in many ways: it one smallest self-replicating organisms, has reduced and highly stable genome (0·8 Mbp), lacks cell wall, grows slowly (generation time 6 h), requires close contact for transmission, distinct disease presentation (atypical pneumonia), pathogenesis which might involve host cell-mediated...

10.1016/s2666-5247(23)00344-0 article EN cc-by-nc-nd The Lancet Microbe 2023-11-23

BackgroundMycoplasma pneumoniae respiratory infections are transmitted by aerosol and droplets in close contact.AimWe investigated global M. incidence after implementation of non-pharmaceutical interventions (NPIs) against COVID-19 March 2020.MethodsWe surveyed detections from laboratories surveillance systems (national or regional) across the world 1 April 2020 to 31 2021 compared them with cases corresponding months between 2017 2020. Macrolide-resistant (MRMp) data were collected...

10.2807/1560-7917.es.2022.27.19.2100746 article EN cc-by Eurosurveillance 2022-05-12
Jean‐Paul Pirnay Sarah Djebara Griet Steurs Johann Griselain Christel Cochez and 95 more Steven De Soir Téa Glonti An Spiessens Emily Vanden Berghe Sabrina I. Green Jeroen Wagemans Cédric Lood Eddie Schrevens Ніна Чанішвілі Mzia Kutateladze Mathieu de Jode Pieter‐Jan Ceyssens Jean-Pierre Draye Gilbert Verbeken Daniël De Vos Thomas Rose Jolien Onsea Brieuc Van Nieuwenhuyse Kim Win Pang Willem‐Jan Metsemakers Dimitri Van der Linden Olga Chatzis Anaïs Eskenazi Ángel L. López Adrien De Voeght Anne‐Françoise Rousseau Anne Tilmanne Daphné Vens J. Gérain Brice Layeux Erika Vlieghe Ingrid Baar Sabrina H. van Ierssel Johan Van Laethem Julien Guiot Sophie De Roock Serge Jennes Saartje Uyttebroek Laura Van Gerven Peter W. Hellings Lieven Dupont Yves Debaveye David Devolder Isabel Spriet Paul De Munter Melissa Depypere Michiel Vanfleteren Olivier Cornu Stijn Verhulst Tine Boiy Stoffel Lamote Thibaut Van Zele Grégoire Wieërs Cécile Courtin David Lebeaux Jacques Sartre Tristan Ferry Frédéric Laurent Kevin Paul Mariagrazia Di Luca Stefan Gottschlich Tamta Tkhilaishvili Novella Cesta Kārlis Rācenis Telma Barbosa Luis Eduardo López-Cortés María Tomás Martin Hübner Truong‐Thanh Pham A. Paul Nagtegaal Jaap ten Oever Johannes M.A. Daniels M.C. Loubert Ghariani Iheb Joshua D. Jones Lesley Hall Matthew J. Young Nana Balarjishvili Marina Tediashvili Yigang Tong Christine H. Rohde Johannes Wittmann Ronen Hazan Ran Nir‐Paz Joana Azeredo В. Н. Крылов David R. Cameron Melissa Pitton Yok‐Ai Que Grégory Resch Shawna McCallin Matthew Dunne Samuel Kilcher Patrick Soentjens Rob Lavigne

Abstract In contrast to the many reports of successful real-world cases personalized bacteriophage therapy (BT), randomized controlled trials non-personalized products have not produced expected results. Here we present outcomes a retrospective observational analysis first 100 consecutive BT difficult-to-treat infections facilitated by Belgian consortium in 35 hospitals, 29 cities and 12 countries during period from 1 January 2008 30 April 2022. We assessed how often positive clinical...

10.1038/s41564-024-01705-x article EN cc-by Nature Microbiology 2024-06-04

ObjectivesTo characterize longitudinal symptoms of mild coronavirus disease 2019 (COVID-19) patients for a period 6 months, to potentially aid in management.MethodsPhone interviews were conducted with 103 COVID-19 Israel over 6-month (April 2020 October 2020). Patients recruited via social media and word mouth interviewed up 4 times, depending on reports their unresolved symptoms. Inclusion criteria required participants be residents aged 18 years or older, positive real-time PCR results...

10.1016/j.cmi.2021.02.008 article EN cc-by-nc-nd Clinical Microbiology and Infection 2021-02-17

<h3>Importance</h3> Despite the high 3-dose vaccination rate among health care workers (HCWs) in Israel, a of SARS-CoV-2 breakthrough infections this group was observed during Omicron wave. As result, Israeli Ministry Health decided to recommend fourth vaccine dose medical staff. <h3>Objective</h3> To evaluate benefit BNT162b2 on infection HCWs. <h3>Design, Setting, and Participants</h3> This multicenter cohort study performed January 2022, first month 4-dose campaign, surge variant All at...

10.1001/jamanetworkopen.2022.24657 article EN cc-by-nc-nd JAMA Network Open 2022-08-02

The use of bacteriophages (phages) is reemerging as a potential treatment option for antibiotic-resistant or nonresolving bacterial infections. Phages are bacteria-specific viruses that may serve personalized therapeutic with minimal collateral damage to the patient microbiome. In 2018 we established Israeli Phage Therapy Center (IPTC) shared initiative Hadassah Medical and Hebrew University Jerusalem, aiming conduct all steps required phage-based solutions, from phage isolation...

10.1093/ofid/ofad221 article EN cc-by-nc-nd Open Forum Infectious Diseases 2023-04-20

ABSTRACT Left ventricular assist devices (LVAD) are increasingly used for management of heart failure; infection remains a frequent complication. Phage therapy has been successful in variety antibiotic refractory infections and is interest treating LVAD infections. We performed retrospective review four patients that underwent five separate courses intravenous (IV) phage with concomitant treatment endovascular Pseudomonas aeruginosa infection. assessed susceptibility, bacterial strain...

10.1128/aac.01728-23 article EN Antimicrobial Agents and Chemotherapy 2024-03-17

Listeria monocytogenes is a foodborne pathogen that causes life-threatening infections in elderly, immunocompromised, and pregnant women. In pregnancy it may cause fetal loss or preterm delivery, the neonate prone to neonatal sepsis death.We created cohort of all L. cases during 10 years (1998-2007) Israel, by comprehensive review hospitals throughout country reported Ministry Health.One hundred sixty-six pregnancy-related listeriosis were identified, resulting yearly incidence 5-25 per 100...

10.1093/cid/ciu504 article EN Clinical Infectious Diseases 2014-06-27

Macrolide resistance in Mycoplasma pneumoniae is often found Asia but rare elsewhere. We report the emergence of macrolide-resistant M. Israel and vivo evolution such during treatment a 6-year-old boy with pneumonia.

10.3201/eid/1706.101558 article EN cc-by 2011-06-01

Objective Stripping of the membranes is an established and widely utilized obstetric procedure associated with higher spontaneous vaginal delivery rates, reduced need for formal induction labor a lower likelihood post-term pregnancy. Due to theoretical concern bacterial seeding during many practitioners choose not sweep in Group B Streptococcus (GBS) colonized patients. We conducted 'the STRIP-G study' order determine whether maternal neonatal outcomes are affected by GBS carrier status...

10.1371/journal.pone.0145905 article EN cc-by PLoS ONE 2015-12-31
Lea Papst Bojana Beović C. Pulcini Emanuele Durante‐Mangoni Jesús Rodríguez‐Baño and 95 more Keith S. Kaye George L. Daikos Lul Raka Mical Paul Lilian M. Abbo P. Abgueguen Benito Almirante Anna Maria Azzini Firouzé Bani‐Sadr Matteo Bassetti Ronen Ben‐Ami B. Beović Guillaume Béraud Élisabeth Botelho-Nevers Germán Bou D. Boutoille André Cabié Bruno Cacopardo Antonio Cascio Nadim Cassir Francesco Castelli Mia Cecala A. Charmillon Catherine Chirouze José Miguel Cisneros Juan Colmenero Nicola Coppola Silvia Corcione G.L. Daikos Daniela Dalla Gasperina Carlos Cabrera Pierre Delobel Debora Di Caprio Emanuele Durante‐Mangoni M. Dupon N. Ettahar M.E. Falagas Marco Falcone M.C. Fariñas E. Faure E. Forestier G. Foti J. Gallagher Gianni Gattuso V. Gendrin Ivan Gentile Daniele Roberto Giacobbe Charalambos Gogos L. Grandiere Perez Y. Hansmann Juan Pablo Horcajada Carmelo Iacobello Jesse T. Jacob Julie Ann Justo Solen Kernéis A. Komnos B. Kotnik Kevorkijan David Lebeaux R. Le Berre C. Lechiche V. Le Moxing F.-X. Lescure M. Libanore M. Martinot Esperanza Merino V. Mondain P. Mondello Miguel Montejo J. Mootien Patricia Muñóz Ran Nir‐Paz Ailuan Pan J.R. Paño‐Pardo Gopi Patel Mical Paul Pérez Rodríguez Lionel Piroth Jason M. Pogue Brian A. Potoski Valérie Pourcher A. Pyrpasopoulou G. Rahav Marco Rizzi Jesús Rodríguez‐Baño M. Salavert Marc H. Scheetz M Sims Gazmend Spahija S. Stefani Aggelos Stefos P.D. Tamma P. Tattevin Andrea Tedesco José Miguel Cisneros Paraskevi Tripolitsioti

10.1016/j.cmi.2018.01.015 article EN publisher-specific-oa Clinical Microbiology and Infection 2018-02-01

Background Mycoplasma pneumoniae is a leading cause of community-acquired pneumonia, with large epidemics previously described to occur every 4 7 years. Aim To better understand the diagnostic methods used detect M . ; M. testing and surveillance in use; identify epidemics; determine detection number per age group, demographics for positive detections, concurrence annual peaks across geographical areas; effect location on timing epidemics. Methods A questionnaire was sent May 2016 experts...

10.2807/1560-7917.es.2020.25.2.1900112 article EN cc-by Eurosurveillance 2020-01-16
Coming Soon ...